Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication

Dongjie Chen,Pengyi Liu,Xiongxiong Lu,Jingfeng Li,Debin Qi,Longjun Zang,Jiayu Lin,Yihao Liu,Shuyu Zhai,Da Fu,Yuanchi Weng,Hongzhe Li,Baiyong Shen

DOI: https://doi.org/10.1186/s13046-024-03042-7

IF: 12.658

2024-04-26

Journal of Experimental & Clinical Cancer Research

Abstract:Immunotherapy has emerged as a potent clinical approach for cancer treatment, but only subsets of cancer patients can benefit from it. Targeting lactate metabolism (LM) in tumor cells as a method to potentiate anti-tumor immune responses represents a promising therapeutic strategy.

oncology

What problem does this paper attempt to address?

The paper attempts to address the relationship between lactate metabolism (LM) and immune therapy response in cancer immunotherapy, and explore its potential as a biomarker for predicting immunotherapy efficacy and survival prognosis.

Specifically, the paper addresses the problem through the following points:
1. **Correlation Analysis**: The study investigated the relationship between lactate metabolism and immune therapy response, finding that tumor cells with higher levels of lactate metabolism are more likely to develop resistance to immune therapy.
2. **Establishment of Lactate Metabolism-Related Signature (LM.SIG)**: Based on a large-scale pan-cancer single-cell RNA sequencing dataset, a lactate metabolism-related gene signature (LM.SIG) was established to predict immune therapy response and survival prognosis.
3. **Machine Learning Model Validation**: Various machine learning algorithms were used to validate the predictive performance of LM.SIG in multiple pan-cancer immune therapy cohorts, demonstrating its effectiveness across different cancer types.
4. **Identification of Potential Targets**: Through CRISPR screening experiments, lactate dehydrogenase A (LDHA) was identified as a potential therapeutic target, and its mechanism of action was validated through in vivo and in vitro experiments.

In summary, the paper aims to reveal the close relationship between lactate metabolism and immune therapy resistance, and develop a pan-cancer applicable lactate metabolism-related signature (LM.SIG) to improve the accuracy of patient selection for immunotherapy.